UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000026039
Receipt No. R000029863
Official scientific title of the study OASIS extracellular matrix clinical efficacy study
Date of disclosure of the study information 2017/03/01
Last modified on 2018/08/10 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study OASIS extracellular matrix clinical efficacy study
Title of the study (Brief title) OASIS study
Region
Japan

Condition
Condition patient having donor site for split-thickness skin graft
Classification by specialty
Plastic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 evaluation of OASIS extracellular matrix efficacy for donor site for split-thickness skin graft
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes pathologic evaluation of donor site after healing
Key secondary outcomes time to healing

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 half side test of extracellular matrix and conventional treatment for split thickness donor site.
the term of intervention is until healing of donor site.
biopsy of donor sites applied OASIS and conventional treatment after healing.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients having split thickness donor site
Key exclusion criteria infectious wound
Target sample size 10

Research contact person
Name of lead principal investigator yutaro yamashita
Organization kyorin university hospital
Division name plastic surgery
Address 2-2, sinkawa 6-chome, mitaka, tokyo, japan
TEL 0422-47-5511
Email thestarstripjp@yahoo.co.jp

Public contact
Name of contact person yutaro yamashita
Organization kyorin university hospital
Division name plastic surgery
Address 2-2, sinkawa 6-chome, mitaka, tokyo, japan
TEL 0422-47-5511
Homepage URL
Email thestarstripjp@yahoo.co.jp

Sponsor
Institute kyorin university hospital
Institute
Department

Funding Source
Organization kyorin university hospital department of plastic surgery
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 杏林大学医学部附属病院

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 31 Day
Anticipated trial start date
2017 Year 03 Month 01 Day
Last follow-up date
2018 Year 03 Month 31 Day
Date of closure to data entry
2018 Year 03 Month 31 Day
Date trial data considered complete
2018 Year 03 Month 31 Day
Date analysis concluded
2018 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 02 Month 07 Day
Last modified on
2018 Year 08 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029863